IGF1 and cancer: Correspondingly, most Mendelian randomization (MR) studies have shown a positive association of IGF1 with different types of cancer (Cornish et al., 2020; Larsson et al., 2020; Murphy et al., 2020a,b; Watts et al., 2021).